Target Name: SALL1
NCBI ID: G6299
Review Report on SALL1 Target / Biomarker Content of Review Report on SALL1 Target / Biomarker
SALL1
Other Name(s): Sal-like protein 1 | Zinc finger protein 794 | ZNF794 | SALL1 variant 1 | Zinc finger protein SALL1 | TBS | HEL-S-89 | HSAL1 | epididymis secretory protein Li 89 | Zinc finger protein Spalt-1 | Spalt like transcription factor 1, transcript variant 1 | Sal-1 | Spalt-like transcription factor 1 | Spalt like transcription factor 1, transcript variant 2 | SALL1_HUMAN | Sal (Drosophila)-like 1 | Sal-like protein 1 (isoform b) | SALL1 variant 2 | HSal1 | spalt like transcription factor 1 | Sal-like protein 1 (isoform a) | zinc finger protein 794 | zinc finger protein Spalt-1 | zinc finger protein SALL1

SALL1: A Protein Involved in Cell Membrane Regulation and Disease

SALL1 (Sal-like protein 1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidney. Its function is not well understood, but it is known to play a role in the regulation of ion channels and the transport of molecules across cell membranes.

SALL1 has also been shown to be involved in a variety of diseases, including neurodegenerative disorders, cancer, and cardiovascular disease. Its potential as a drug target or biomarker makes it an attractive target for researchers to study.

One of the reasons for the interest in SALL1 is its ability to interact with a variety of different molecules. Its extracellular domain contains a region that is similar to that of known interactors, such as the protein kinase PDK4, which can modulate its activity.

Additionally, SALL1 has been shown to interact with its downstream targets, such as the protein known as TRPV6, which is involved in the regulation of pain and temperature. This interaction suggests that SALL1 may be involved in the regulation of important physiological processes that are regulated by its downstream targets.

Another potential mechanism by which SALL1 may be involved in the regulation of ion channels is through its interaction with the protein known as NHE1. NHE1 is a subunit of the Na+/K+ ATPase, which is responsible for regulating the movement of ions into and out of cells.

SALL1 has been shown to interact with NHE1 and can modulate its activity. This interaction suggests that SALL1 may be involved in the regulation of ion channels, which is important for the proper functioning of many different physiological processes.

In addition to its potential role in the regulation of ion channels, SALL1 is also known to be involved in the regulation of protein transport. Its extracellular domain contains a region that is similar to that of known transport proteins, which can modulate their activity.

SALL1 has been shown to interact with the protein known as efflux pumps, which are involved in the regulation of protein transport out of cells. This interaction suggests that SALL1 may be involved in the regulation of protein transport, which is important for the proper functioning of many different physiological processes.

In conclusion, SALL1 is a protein that has been shown to play a role in the regulation of a variety of different processes in the body. Its interaction with other molecules, including PDK4, TRPV6, NHE1, and efflux pumps, suggests that it may be a valuable drug target or biomarker for a variety of different diseases. Further research is needed to fully understand its function and to determine its potential as a drug.

Protein Name: Spalt Like Transcription Factor 1

Functions: Transcriptional repressor involved in organogenesis. Plays an essential role in ureteric bud invasion during kidney development

The "SALL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SALL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SALL2 | SALL3 | SALL4 | SALL4P7 | SALRNA2 | SAMD1 | SAMD10 | SAMD11 | SAMD12 | SAMD12-AS1 | SAMD13 | SAMD14 | SAMD15 | SAMD3 | SAMD4A | SAMD4A-AS1 | SAMD4B | SAMD5 | SAMD7 | SAMD8 | SAMD9 | SAMD9L | SAMHD1 | SAMM50 | SAMMSON | SAMSN1 | SAMSN1-AS1 | SANBR | SAP130 | SAP18 | SAP30 | SAP30-DT | SAP30BP | SAP30L | SAP30L-AS1 | SAPCD1 | SAPCD1-AS1 | SAPCD2 | SAR1A | SAR1B | SARAF | SARDH | SARM1 | SARNP | SARS1 | SARS2 | SART1 | SART3 | SASH1 | SASH3 | SASS6 | SAT1 | SAT1-DT | SAT2 | SATB1 | SATB1-AS1 | SATB2 | SATB2-AS1 | SATL1 | SAV1 | SAXO1 | SAXO2 | SAYSD1 | SBDS | SBDSP1 | SBF1 | SBF1P1 | SBF2 | SBF2-AS1 | SBK1 | SBK2 | SBK3 | SBNO1 | SBNO2 | SBSN | SBSPON | SC5D | SCAANT1 | SCAF1 | SCAF11 | SCAF4 | SCAF8 | SCAI | SCAMP1 | SCAMP1-AS1 | SCAMP2 | SCAMP3 | SCAMP4 | SCAMP5 | SCAND1 | SCAND2P | SCAND3 | SCAP | SCAPER | SCARA3 | SCARA5 | SCARB1 | SCARB2 | SCARF1 | SCARF2